However, as suggested by the present study, sumanirole remains a valuable tool in lead optimization, drug discovery, and animal models, where the novel D2R–M1R interaction may provide a rationale to target specific receptor subtypes in the treatment of PD. Here, DRD2 is linked to Parkinson disease.